Pharmacology
Latest Content
Newly launched firm secures £4.3 million seed funding to target drug-resistant bacteria
Glox Therapeutics, a company developing precision antibiotic therapies, has raised £4.3 million in seed funding to develop effective targeted therapeutics against antibiotic-resistant bacteria.
News
Newly launched firm secures £4.3 million seed funding to target drug-resistant bacteria
Glox Therapeutics, a company developing precision antibiotic therapies, has raised £4.3 million in seed funding to develop effective targeted therapeutics against antibiotic-resistant bacteria.
In Depth
Knowledge is power: In silico modelling of Covid-19
Scientific research takes time. But, as the Covid-19 pandemic highlighted, sometimes that’s a luxury scientists can’t afford, says ≈. Experimentation and data guide us to the ‘right’ decision based o…
Comment And Analysis
Quantum of challenge
Its market value will soon be measured in billions, yet quantum computing has yet to reach a marketable state and don’t expect it to replace classic computers, says Scott Jordan. So what’s all the fu…
Interviews
It’s all just a matter of perception
In anticipation of the announcement of this year’s competition winners, we asked previous winners a bit more about themselves and the process that led to their Olympus Image of the Year light microsc…
